Cwm, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Cwm, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Cwm, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,154 shares of AMPH stock, worth $37,170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,154
Previous 996
15.86%
Holding current value
$37,170
Previous $48,000
10.42%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
36.8MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$191 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$87.4 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$62.7 Million0.22% of portfolio
-
Td Asset Management Inc1.84MShares$59.3 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$52 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.58B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...